Notably, epimedin C was found to alleviate the abnormalities of lipid metabolism in T2DM mice mainly by regulating the expression levels of Pck1, Pla2g12b, Apob, and Cyp4a14. Here, PLA2G12B is linked to type 2 diabetes mellitus.